Strategic Sponsorship Will Provide Innovative Technology and Nurture
Promising Biotechnology Startup
Company Website:
http://www.agilent.com/go/news
SANTA CLARA, Calif. & CAMBRIDGE, Mass. -- (Business Wire)
Agilent
Technologies Inc. (NYSE: A) has announced a platinum sponsorship
agreement with LabCentral,
a biotech innovation hub based in Cambridge, Massachusetts. LabCentral
is an independent, shared laboratory space designed as a launchpad for
high-potential life sciences and biotech startups.
As a platinum sponsor, Agilent will equip LabCentral’s shared laboratory
workspace with a variety of Agilent technology. Instruments will include
a high-resolution mass spectrometry system, as well as a cell analysis
extracellular flux (XF) analyzer. Also, Agilent will fund a
high-potential biotech startup company at LabCentral via a contest to
award a Golden Ticket. The Agilent-sponsored Golden Ticket is good for
one individual bench in LabCentral’s shared facility for one year.
Online applications for the Golden Ticket open on October 2, 2017, and
will be accepted until November 1, 2017, at 12:00 Noon PST. The
finalists will present to an esteemed review panel at a public event at
LabCentral on November 16, 2017. Learn more at http://www.agilent.com/en/promotions/goldenticket.
“Agilent is committed to supporting the next generation of scientific
pioneers, and what better place to do so than in one of our nation’s
fastest growing biotech communities,” said Darlene Solomon, senior vice
president and chief technology officer for Agilent. “We couldn’t be more
proud to offer our technologies to LabCentral residents, and our support
to emerging biotech to help accelerate innovation in critical areas that
can improve human health.”
“We’re honored to welcome Agilent as a platinum sponsor, which will
enable us to build out significant extra analytical capacity for our
startups to use,” said Johannes Fruehauf, M.D., Ph.D., cofounder, and
president for LabCentral. “In addition, we are especially happy that
Agilent has agreed to become a Golden Ticket sponsor. The team has come
up with an exciting process for identifying the winner, and I look
forward to participating.”
LabCentral offers a supportive and nurturing environment designed to
inspire interaction and collaboration. Startups work side by side on
some of the most exciting potential breakthroughs in diagnostics and
therapeutics, and prevention — across the spectrum of diseases.
Biopharma is a fast-growing market for Agilent, and Cambridge is a hub
of innovation in this field.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences,
diagnostics, and applied chemical markets.With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to its
customers’ most challenging questions. The company generated revenues of
$4.20 billion in fiscal 2016 and employs about 13,000 people worldwide.
Information about Agilent is available at www.agilent.com.
About LabCentral (www.labcentral.org;
twitter @labcentral)
LabCentral is a first-of-its-kind shared laboratory workspace in the
heart of the Kendall Square, Cambridge, biotech innovation hub. Designed
as a launchpad for high-potential life-sciences and biotech startups, it
offers everything startups need to begin laboratory operations on day
one and move their science forward faster and more cost-efficiently.
This includes: fully permitted laboratory and office space, first-class
facility and administrative support, skilled laboratory personnel, a
domain-relevant expert speaker series ‒ as well as the other critical
services and support. A private, nonprofit institution, LabCentral’s
first site opened in 2013, thanks to a capital grant from the
Massachusetts Life Sciences Center, with support from its real-estate
partner, MIT. Founding sponsors include Triumvirate Environmental and
Johnson & Johnson Innovation.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170919005400/en/
Contacts:
Agilent Technologies, Inc.
Naomi Goumillout, +1-781-266-2819
naomi.goumillout@agilent.com
or
LabCentral
Caroline
A. Grossman +1-781-771-5579
cgrossman@labcentral.org
Source: Agilent Technologies, Inc.
© 2024 Canjex Publishing Ltd. All rights reserved.